Plasminogen activators in inflammation and sepsis.
Mortality of severe sepsis remains at 40% to 50%. Intensive efforts over the past two decades have only marginally improved outcome. Improving outcome in sepsis depends on understanding its pathophysiology, which involves triggers, responses of the organism, and dysfunction. Stress, injury, or infection trigger host responses, including local and systemic orchestrated mechanisms. Dysfunction and outcome depend on both trigger and response. Blood coagulation, inflammation, immunity, and fibrinolysis are critical components of the organism's responses. Understanding their role in sepsis pathophysiology is the key to effective treatment. Relevant studies were identified by a systematic literature search, complemented by manual search of individual citations. Using PubMed, 'sepsis' yields more than 62,000 references, 'plasminogen activators' more than 21,000. The selection of citations was guided by preference for reviews that expand important threads of argumentation. Single original studies were included when relevant to critical points. This analytical review describes the essential elements of pathophysiology and the current status of sepsis treatment. Based on this context, an emerging therapeutic option will be discussed: plasminogen activators.
Pechlaner
Ch
Ch
Division of General Internal Medicine, Department of Internal Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck. Christoph.Pechlaner@uibk.ac.at
D005342:Fibrinolysis; D006706:Homeostasis; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D010960:Plasminogen Activators / Q000502:physiology*; D018805:Sepsis / Q000503:physiopathology*; D013312:Stress, Physiological / Q000503:physiopathology; D014947:Wounds and Injuries / Q000503:physiopathology
D010960:Plasminogen Activators